VPS35 and Parkinson disease: We have recently described D620N VPS35 knock-in mice that develop robust age-related nigral dopaminergic neurodegeneration, a key hallmark of Parkinson’s disease, as well as widespread axonal damage and tau-positive neuropathology.15